Psychiatric Deprescribing: A Narrative Review

被引:3
作者
Harding, Shari L. [1 ,5 ]
Ellis, Kerri A. [2 ]
Boisseau, John [3 ]
Petreca, Victor [4 ]
机构
[1] Univ Massachusetts, Chan Med Sch, Worcester, MA USA
[2] Univ Rhode Isl, Kingston, RI USA
[3] LifeStance Hlth Inc, Boston, MA USA
[4] Boston Coll, Chestnut Hill, MA USA
[5] Univ Massachusetts, Tan Chingfen Grad Sch Nursing, Chan Med Sch, Assoc Prof Nursing & Psychiat, 55 Lake Ave North, Worcester, MA 01655 USA
关键词
deprescriptions; polypharmacy; drug tapering; mental disorders; MENTAL-HEALTH; DECISION-MAKING; MEDICATION; CARE;
D O I
10.1177/10783903231185353
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
OBJECTIVE: Psychiatric deprescribing is an intervention where psychiatric medications are reduced or discontinued with the goal to improve health and reduce unnecessary risks. The purpose of this study was to synthesize the literature related to psychiatric deprescribing to discuss practice and research implications. METHODS: A structured search of the literature was conducted from May to September 2022, yielding 29 articles meeting inclusion criteria. Articles were reviewed and synthesized. RESULTS: Psychiatric deprescribing is a complex process with many potential facilitators and barriers. The extant literature provides insight into current gaps in knowledge and implications for clinical practice and research. CONCLUSIONS: In current clinical practice, psychiatric deprescribing is a priority but there are significant barriers. Several areas of future research could be pursued to better support evidence-based practice in this area.
引用
收藏
页码:810 / 818
页数:9
相关论文
共 45 条
  • [1] Agency for Healthcare Research and Quality, 2022, NUMB PEOPL PURCH 100
  • [2] [Anonymous], 1994, Am J Psychiatry, V151, P1
  • [3] Branford D., 2020, J PRESCRIBING PRACTI, V2, P460, DOI [10.12968/jprp.2020.2.8.460, DOI 10.12968/JPRP.2020.2.8.460]
  • [4] Brody Debra J, 2020, NCHS Data Brief, P1
  • [5] Commonwealth of Massachusetts, 2019, MASSHEALTH DRUG LIST
  • [6] Enhancing metabolic monitoring for children and adolescents using second-generation antipsychotics
    Coughlin, Mary
    Goldie, Catherine L.
    Tregunno, Deborah
    Tranmer, Joan
    Kanellos-Sutton, Marina
    Khalid-Khan, Sarosh
    [J]. INTERNATIONAL JOURNAL OF MENTAL HEALTH NURSING, 2018, 27 (03) : 1188 - 1198
  • [8] Collaborative Deprescribing in Borderline Personality Disorder: A Narrative Review
    Fineberg, Sarah K.
    Gupta, Swapnil
    Leavitt, Jacob
    [J]. HARVARD REVIEW OF PSYCHIATRY, 2019, 27 (02) : 75 - 86
  • [9] What I have learnt from helping thousands of people taper off antidepressants and other psychotropic medications
    Framer, Adele
    [J]. THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2021, 11
  • [10] Deprescribing anticholinergic medication in the community mental health setting: A quality improvement initiative
    Gannon, Jessica M.
    Lupu, Ana
    Brar, Jaspreet
    Brandt, Myranda
    Zawacki, Susanna
    John, Shirley
    Carl, Kevin
    Chengappa, K. N. Roy
    [J]. RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2021, 17 (10) : 1841 - 1846